Source: Biomedicine & Pharmacotherapy. Unidade: ICB
Assunto: IMUNOLOGIA
ABNT
TEIXEIRA, Sarah Fernandes et al. Evaluation of cytotoxic effect of the combination of a pyridinyl carboxamide derivative and oxaliplatin on NCI-H1299 human non-small cell lung carcinoma cells. Biomedicine & Pharmacotherapy, v. 84, p. 1019-1028, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.biopha.2016.10.025. Acesso em: 18 set. 2024.APA
Teixeira, S. F., Azevedo, R. A., Silva, A. C., Braga, R. C., Jorge, S. D., Barbuto, J. A. M., et al. (2016). Evaluation of cytotoxic effect of the combination of a pyridinyl carboxamide derivative and oxaliplatin on NCI-H1299 human non-small cell lung carcinoma cells. Biomedicine & Pharmacotherapy, 84, 1019-1028. doi:10.1016/j.biopha.2016.10.025NLM
Teixeira SF, Azevedo RA, Silva AC, Braga RC, Jorge SD, Barbuto JAM, Andrade CH, Ferreira AK. Evaluation of cytotoxic effect of the combination of a pyridinyl carboxamide derivative and oxaliplatin on NCI-H1299 human non-small cell lung carcinoma cells [Internet]. Biomedicine & Pharmacotherapy. 2016 ; 84 1019-1028.[citado 2024 set. 18 ] Available from: https://doi.org/10.1016/j.biopha.2016.10.025Vancouver
Teixeira SF, Azevedo RA, Silva AC, Braga RC, Jorge SD, Barbuto JAM, Andrade CH, Ferreira AK. Evaluation of cytotoxic effect of the combination of a pyridinyl carboxamide derivative and oxaliplatin on NCI-H1299 human non-small cell lung carcinoma cells [Internet]. Biomedicine & Pharmacotherapy. 2016 ; 84 1019-1028.[citado 2024 set. 18 ] Available from: https://doi.org/10.1016/j.biopha.2016.10.025